MIRA INFORM REPORT

 

 

 

 

Report Date :

19.04.2014

 

IDENTIFICATION DETAILS

 

Name :

ARYSTA LIFESCIENCE CORPORATION

 

 

Registered Office :

St Luke’s Tower 38/39F, 8-1 Akashicho Chuoku Tokyo 104-0044

 

 

Country :

Japan

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

April 1977

 

 

Legal Form :

Limited Company

 

 

Line of Business :

A trading house for importer, exporter and wholesaler of agrochemicals, pharma-ceuticals intermediates & materials, cosmetics raw materials, health foods, organic chemical intermediates, veterinary products including veterinary medicines & fee additives

 

 

No. of Employees :

100

 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Japan

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name

 

ARYSTA LIFESCIENCE CORPORATION

 

 

REGD NAME

 

Arysta LifeScience KK

 

 

MAIN OFFICE

 

St Luke’s Tower 38/39F, 8-1 Akashicho Chuoku Tokyo 104-0044 JAPAN

Tel: 03-3547-4500     Fax: 03-3547-4699

      URL                        http://www.arystalifescience.com

E-Mail address:            info@arystalifescience.com

 

 

ACTIVITIES

 

Import, export, wholesale of agrochemicals, pharmaceutical intermediates

 

 

BRANCHES

 

Sapporo, Osaka, Fukuoka

 

 

OVERSEAS

 

Arysta LifeScience N America, Arysta LifeScience Europe, Africa & Mid East,

Arysta LifeScience S America, Arysta LifeScience Haesom Corp (Korea),

Bloomers Growers (New Zealand), Arysta LifeScience Maqyarorszy Kft

 (Hungary), Callivoire (Cote D’ivoir) (--subsidiaries)

 

 

OFFICERS

 

WAYNE HEWETT, PRES          Rudorf Van Houten, rep dir

Christopher Richards, ch            John Coyle, dir

Paul Mullins, dir             Alexander Emery, dir

 

Yen Amount:     In million Yen, unless otherwise stated

 

SUMMARY

 

FINANCES        FAIR                             A/SALES          Yen 12,545 M

PAYMENTSNo Complaints    CAPITAL           Yen 59,399 M

TREND SLOW                          WORTH            Yen 53,282 M

STARTED         1977                             EMPLOYES      100

 

COMMENT

 

TRADING HOUSE SPECIALIZING IN AGROCHEMICALS & PHARMACEU-TICAL INTERMEDIATES, OWNED BY IEIL JAPAN.

 

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS

                       

 

HIGHLIGHTS

           

The subject company was established jointly by Tomen Corp (now Toyota Tsusho Corp) and Nichimen Corp (now Sojitz Corp) in order to advance into new area of life science: agrochemicals and pharmaceutical chemicals.  This is a trading house for import, export and wholesale of agrochemicals & pharmaceutical intermediates.  Handles a wide range of brands (See OPERATION).  Active in overseas expansion.  The ownership of the firm changed to IEIL Japan Co, a capital fund investor owned by IEIL Ireland (Permira Funds), in Jun/2008.  Domestic clients include major pharmaceuticals & chemicals mfrs, nationwide. 

 

 

FINANCIAL INFORMATION

 

The sales volume for Dec/2011 fiscal term amounted to Yen 12,545 million, a 31% down from Yen 18,182 million in the previous term.  The operations continued in the red to register Yen 20,400 million recurring loss and Yen 9,525 million net losses, respectively, compared with Yen 13,204 million recurring loss and Yen 11,154 million net losses, respectively, a year ago.

 

For the current term ending Dec 2012 the operations are projected to come back to profitability but still limited to a minimum amount post-taxes, on a 2% rise in turnover, to Yen 12,800 million.  .

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 


REGISTRATION

 

Date Registered:            Apr 1977

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         1,187,986 shares

Issued:                1,187,986 shares

Sum:                   Yen 59,399 million

 

Major shareholders (%): IEIL Japan Co Ltd* (Industrial Equity Investment Ltd) (100)

 

* Investment fund company & management, owned by IEIL Ireland (Industrial Equity Investment Ltd), acquired the firm in Jun/2008.

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

 

Activities: A trading house for import, export and wholesale of agrochemicals, pharma-ceuticals intermediates & materials, cosmetics raw materials, health foods, organic chemical intermediates, veterinary products including veterinary medicines & fee additives, others (--100%).

 

(Handling Brands)

Select (Registered), Captain, Everest (Registered), Orthene (Registered), Elevate Registered), Clutch, Eminent, Monitor, CaptEvate, Maestro, other.

 

Clients: [Pharmaceutical mfrs, chemical firms, wholesalers] Takeda Chemical Ind,

            Toyota Tsusho Corp, Sojitz Corp, Sumitomo Chemical, Toyo Green Inc, Hokko Chemical

            Ind, Yonezawa Chemical Co, other.  

            No. of accounts: 1,000

            Domestic areas of activities: Nationwide

 

Suppliers: [Mfrs, wholesalers] Takeda Chemical Ind, Nissan Chemical Ind, Kumiai Chemical Ind, Nippon Soda Co, Yonezawa Chemical Co, other.

 

Payment record: No Complaints

 

Location: Business area in Tokyo.  Office premises at the caption address are leased and maintained satisfactorily.

 

Bank References:

Aozora Bank (H/O)

MUFG (Marunouchi)

Relations: Satisfactory

 

 

 

FINANCES

(In Million Yen)

 

       Terms Ending:

31/12/2012

31/12/2011

31/12/2010

31/12/2009

Annual Sales

　

12,800

12,545

18,182

15,913

Recur. Profit

　

0

-20,400

-13,204

-20,836

Net Profit

　

0

-9,525

-11,154

-39,439

Total Assets

　

　

234,220

240,679

161,505

Current Assets

　

　

9,378

9,762

11,213

Current Liabs

　

　

25,493

17,935

15,784

Net Worth

　

　

53,282

62,829

73,915

Capital, Paid-Up

　

　

59,399

59,399

59,399

Div.P.Share(¥)

　

　

0.00

0.00

0.00

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

2.03

-31.00

14.26

-47.83

    Current Ratio

 

..

36.79

54.43

71.04

    N.Worth Ratio

..

22.75

26.10

45.77

    R.Profit/Sales

 

0.00

-162.61

-72.62

-130.94

    N.Profit/Sales

0.00

-75.93

-61.35

-247.84

    Return On Equity

..

-17.87

-17.75

-53.36

 

Note: Forecast (or estimated) for the 31/12/2012 fiscal term.

 

           


FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.60.38

UK Pound

1

Rs.101.63

Euro

1

Rs.83.57

 

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.